1. Home
  2. ZURA vs GLOO Comparison

ZURA vs GLOO Comparison

Compare ZURA & GLOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$5.75

Market Cap

521.8M

Sector

Health Care

ML Signal

HOLD

GLOO

Gloo Holdings Inc.

N/A

Current Price

$6.15

Market Cap

417.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
ZURA
GLOO
Founded
2022
2013
Country
United States
United States
Employees
30
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
521.8M
417.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZURA
GLOO
Price
$5.75
$6.15
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$13.00
$13.75
AVG Volume (30 Days)
604.0K
41.3K
Earning Date
05-07-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$306.81
Revenue Next Year
N/A
$95.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.99
$4.63
52 Week High
$7.25
$9.91

Technical Indicators

Market Signals
Indicator
ZURA
GLOO
Relative Strength Index (RSI) 44.69 56.02
Support Level $5.35 $4.91
Resistance Level $5.75 $6.25
Average True Range (ATR) 0.36 0.59
MACD -0.00 0.12
Stochastic Oscillator 22.51 54.98

Price Performance

Historical Comparison
ZURA
GLOO

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About GLOO Gloo Holdings Inc.

Gloo Holdings Inc is engaged in building a technology platform company. It has provided a breadth of products, services, and solutions to the two primary stakeholders at the core of the faith and flourishing ecosystem: (1) network capability providers (NCPs) and (2) the churches and frontline organizations (CFLs) it serves. The company serves as a digital infrastructure between NCPs and CFLs. By facilitating efficient exchange between the two, Gloo enables both sides to succeed; CFLs gain access to resources and NCPs benefit from efficient distribution and targeted reach. This creates a virtuous cycle, strengthening the platform with each interaction. The Gloo platform includes a suite of technology, marketplace, and service solutions offered directly from Gloo or from Gloo's subsidiaries.

Share on Social Networks: